Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 424B5 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. S-1 Offering Registration Statement
  4. 424B4 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-1 Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. UPLOAD Other SEC-generated Letter
  18. UPLOAD Other SEC-generated Letter
  19. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 19 filings